Login to Your Account



The Speed of mTOR

At Tumor Oxygen Levels, mTOR Is Loner, Complicating Targeting

By Anette Breindl
Science Editor

Monday, April 1, 2013
By using a single-cell proteomics approach, researchers have discovered that the mammalian target of rapamycin, or mTOR protein, may be hardest to drug at oxygen levels that are often found in tumors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription